Amarin Corp Plcuk (AMRN) Share-based Compensation (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Share-based Compensation of $2.3 million for Q1 2026, down 46.13% YoY from $4.3 million in Q1 2025, and up 44.33% sequentially from $1.6 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Share-based Compensation (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Share-based Compensation across 17 years of filings, most recently posting $2.3 million for Q1 2026.

  • In Q1 2026, Share-based Compensation fell 46.13% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $11.9 million (down 28.98% YoY), while the FY2025 annual figure was $13.9 million, down 21.28% from the prior year.
  • Share-based Compensation grew to $2.3 million in Q1 2026, from $1.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for AMRN reached as high as $8.6 million in Q2 2022 and fell as low as $1.6 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $4.6 million (2023), against an average of $4.5 million.
  • Annual changes were most pronounced in 2022 — Share-based Compensation soared 248.77% — and 2023, when it sank 78.78%.
  • A 5-year view of Share-based Compensation shows it stood at $6.6 million in 2022, then declined by 29.72% to $4.6 million in 2023, then dropped by 26.79% to $3.4 million in 2024, then plunged by 52.53% to $1.6 million in 2025, then surged by 44.33% to $2.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $2.3 million, $1.6 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 161.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 300.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 444.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 185.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 218.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 272.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 2.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.33 Mn
Mar 31, 2026 2.33 Mn
Dec 31, 2025 1.62 Mn
Dec 31, 2025 1.62 Mn
Sep 30, 2025 1.96 Mn
Sep 30, 2025 1.96 Mn
Jun 30, 2025 6.04 Mn
Jun 30, 2025 6.04 Mn
Mar 31, 2025 4.33 Mn
Mar 31, 2025 4.33 Mn
Dec 31, 2024 3.40 Mn
Dec 31, 2024 3.40 Mn
Sep 30, 2024 4.70 Mn
Sep 30, 2024 4.70 Mn
Jun 30, 2024 4.39 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 5.22 Mn
Mar 31, 2024 5.22 Mn
Dec 31, 2023 4.65 Mn
Dec 31, 2023 4.65 Mn